Press Releases Mithra Pharmaceuticals S.A.

Equities

MITRA

BE0974283153

Real-time Euronext Bruxelles Other stock markets 09:05:26 26/04/2024 pm IST			5-day change	1st Jan Change
0.216 ^EUR	-1.82%		-2.48%	-82.78%

29/04	Mithra Pharmaceuticals to Postpone the Publication of Its Annual Report 2023	CI
22/04	Mithra Pharmaceuticals Obtains Court Protection Measures	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mithra updates on offers received in the context of its monetization process and on its Annual Report 2023	29/04	GL
Mithra secures court protection measures to advance monetization process	22/04	GL
Early data from Mithra's ESTELLE pediatric study to be presented at two upcoming congresses	17/04	AQ
Mithra Pharmaceuticals S A : reaches milestone in estetrol skin study	08/04	PU
Mithra reports full year 2023 financial results	08/03	GL
Mithra announces changes to its executive management	06/03	AQ
Mithra announces changes to its executive management	05/03	GL
Mithra announces changes to its executive management	05/03	AQ
Mithra initiates monetization process, receives bridge loan from existing lenders	05/03	GL
Mithra - DONESTA safety study for menopause completes treatment phase and advances to data management and reporting phase	29/02	AQ
DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase	29/02	GL
Mithra sells shares in Mayne Pharma	15/02	GL
Mithra Announces its 2024 Financial Calendar	08/02	AQ
Mithra updates on cash position	06/02	GL
Mithra updates on cash position	06/02	AQ
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025	26/01	AQ
Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA in Israel	22/12	AQ
Mithra Pharmaceuticals S A : Publication of a transparency notification received from The Goldman Sachs Group Inc.	22/12	PU
Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israel	21/12	GL
Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israel	21/12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Mithra Pharmaceuticals S.A.

Equities

MITRA

BE0974283153

Press Releases

Filters